A detailed history of Novare Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Novare Capital Management LLC holds 52,851 shares of ABBV stock, worth $10.8 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
52,851
Previous 46,779 12.98%
Holding current value
$10.8 Million
Previous $8.02 Million 30.09%
% of portfolio
0.9%
Previous 0.73%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $994,836 - $1.21 Million
6,072 Added 12.98%
52,851 $10.4 Million
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $6.49 Million - $7.58 Million
41,920 Added 862.73%
46,779 $8.02 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $262,584 - $299,190
-1,643 Reduced 25.27%
4,859 $884,000
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $36,601 - $41,222
-266 Reduced 3.93%
6,502 $1.01 Million
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $8,015 - $9,279
-60 Reduced 0.88%
6,768 $1.01 Million
Q2 2023

Jul 28, 2023

SELL
$132.51 - $164.9 $22,526 - $28,033
-170 Reduced 2.43%
6,828 $919,000
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $35,429 - $40,802
-245 Reduced 3.38%
6,998 $1.12 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $243,425 - $291,931
-1,760 Reduced 19.55%
7,243 $0
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $49,791 - $57,108
-371 Reduced 3.96%
9,003 $1.21 Million
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $299,185 - $380,363
-2,174 Reduced 18.83%
9,374 $1.44 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $370,731 - $459,973
-2,809 Reduced 19.57%
11,548 $1.87 Million
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $336,255 - $425,460
-3,130 Reduced 17.9%
14,357 $1.94 Million
Q3 2021

Nov 04, 2021

SELL
$106.4 - $120.78 $45,007 - $51,089
-423 Reduced 2.36%
17,487 $1.89 Million
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $6.11 Million - $6.81 Million
-58,097 Reduced 76.44%
17,910 $2.02 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $165,726 - $182,444
1,620 Added 2.18%
76,007 $8.23 Million
Q4 2020

Feb 01, 2021

BUY
$80.49 - $108.67 $125,000 - $168,764
1,553 Added 2.13%
74,387 $7.97 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $142,438 - $167,176
1,658 Added 2.33%
72,834 $6.38 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $229,134 - $306,616
3,123 Added 4.59%
71,176 $6.99 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $313,147 - $474,770
4,855 Added 7.68%
68,053 $5.19 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $9,449 - $11,822
131 Added 0.21%
63,198 $5.6 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $413,463 - $497,101
6,565 Added 11.62%
63,067 $4.78 Million
Q2 2019

Aug 08, 2019

SELL
$65.7 - $83.98 $41,916 - $53,579
-638 Reduced 1.12%
56,502 $4.11 Million
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $573,921 - $675,477
7,440 Added 14.97%
57,140 $4.61 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $208,949 - $257,690
2,684 Added 5.71%
49,700 $4.58 Million
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $15,114 - $16,802
170 Added 0.36%
47,016 $4.36 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $205,955 - $243,691
-2,294 Reduced 4.67%
46,846 $4.34 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $459,129 - $614,817
-4,990 Reduced 9.22%
49,140 $4.65 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $71,200 - $78,076
-795 Reduced 1.45%
54,130 $5.24 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $3.84 Million - $4.9 Million
54,925
54,925 $4.88 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.